Table of Contents

2019-2024 Global Infertility Therapies Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Infertility Therapies Market Size 2014-2024
  • 2.1.2 Infertility Therapies Market Size CAGR by Region
• 2.2 Infertility Therapies Segment by Type
  • 2.2.1 Female Infertility Testing
  • 2.2.2 Male Infertility Testing
• 2.3 Infertility Therapies Market Size by Type
  • 2.3.1 Global Infertility Therapies Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Infertility Therapies Market Size Growth Rate by Type (2014-2019)
• 2.4 Infertility Therapies Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Clinics
  • 2.4.3 Fertility Centers
  • 2.4.4 Others
• 2.5 Infertility Therapies Market Size by Application
  • 2.5.1 Global Infertility Therapies Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Infertility Therapies Market Size Growth Rate by Application (2014-2019)

3 Global Infertility Therapies by Players

• 3.1 Global Infertility Therapies Market Size Market Share by Players
  • 3.1.1 Global Infertility Therapies Market Size by Players (2017-2019)
  • 3.1.2 Global Infertility Therapies Market Size Market Share by Players (2017-2019)
• 3.2 Global Infertility Therapies Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Infertility Therapies by Regions

• 4.1 Infertility Therapies Market Size by Regions
• 4.2 Americas Infertility Therapies Market Size Growth
• 4.3 APAC Infertility Therapies Market Size Growth
• 4.4 Europe Infertility Therapies Market Size Growth
• 4.5 Middle East & Africa Infertility Therapies Market Size Growth

5 Americas

• 5.1 Americas Infertility Therapies Market Size by Countries
• 5.2 Americas Infertility Therapies Market Size by Type
• 5.3 Americas Infertility Therapies Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Infertility Therapies Market Size by Countries
• 6.2 APAC Infertility Therapies Market Size by Type
• 6.3 APAC Infertility Therapies Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Infertility Therapies by Countries
• 7.2 Europe Infertility Therapies Market Size by Type
• 7.3 Europe Infertility Therapies Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Infertility Therapies by Countries
• 8.2 Middle East & Africa Infertility Therapies Market Size by Type
• 8.3 Middle East & Africa Infertility Therapies Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Infertility Therapies Market Forecast

• 10.1 Global Infertility Therapies Market Size Forecast (2019-2024)
• 10.2 Global Infertility Therapies Forecast by Regions
  • 10.2.1 Global Infertility Therapies Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Infertility Therapies Forecast by Type
• 10.8 Global Infertility Therapies Forecast by Application

11 Key Players Analysis

• 11.1 Merck
  • 11.1.1 Company Details
  • 11.1.2 Infertility Therapies Product Offered
  • 11.1.3 Merck Infertility Therapies Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Merck News
• 11.2 Abbott
  • 11.2.1 Company Details
  • 11.2.2 Infertility Therapies Product Offered
  • 11.2.3 Abbott Infertility Therapies Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Abbott News
• 11.3 BioMerieux
  • 11.3.1 Company Details
  • 11.3.2 Infertility Therapies Product Offered
  • 11.3.3 BioMerieux Infertility Therapies Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 BioMerieux News
• 11.4 BioZhena
  • 11.4.1 Company Details
  • 11.4.2 Infertility Therapies Product Offered
  • 11.4.3 BioZhena Infertility Therapies Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 BioZhena News
• 11.5 Ferring Pharmaceuticals
  • 11.5.1 Company Details
  • 11.5.2 Infertility Therapies Product Offered
  • 11.5.3 Ferring Pharmaceuticals Infertility Therapies Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Ferring Pharmaceuticals News

...

12 Research Findings and Conclusion

Infertility is usually defined as the inability to become pregnant after one year of vaginal intercourse without birth control.

According to this study, over the next five years the Infertility Therapies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Infertility Therapies business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Infertility Therapies market by product type, application, key companies and key regions.

This study considers the Infertility Therapies value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Female Infertility Testing
Male Infertility Testing
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Fertility Centers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
Abbott
BioMerieux
BioZhena
Ferring Pharmaceuticals
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Infertility Therapies market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Infertility Therapies market by identifying its various subsegments.
Focuses on the key global Infertility Therapies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Infertility Therapies with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Infertility Therapies submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.